Clinical Data launches 454 Genome sequencer
USA based biotechnology firm Clinical Data says that its Cogenics division has launched the 454 Genome Sequencer FLX system at its facility in Meylan, France. The announcement follows eight weeks after the firm signed a co-marketing agreement with Swiss drug major Roche, which will see the companies collaborate on the provision of "next generation" sequencing services.
Clinical Data said that the launch broadens its portfolio of services to include whole genome sequencing, transcriptomic analysis, metagenomics, EST analysis and small nuclear RNA identification. The company added that Cogenics, together with its sister organization PGxHealth, will be exhibiting the system at the forthcoming European Society for Human Genetics Conferences in Nice, France.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze